We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

8 hedge funds and large institutions have $4.62M invested in Abiomed Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 499 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

98% less funds holding

Funds holding: 517 → 8 (-509)

99% less call options, than puts

Call options by funds: $437K | Put options by funds: $45.7M

100% less capital invested

Capital invested by funds: $10.5B → $4.62M (-$10.5B)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 499

Holders
8
Holders Change
-509
Holders Change %
-98.45%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
6
Closed
499
Calls
$437K
Puts
$45.7M
Net Calls
-$45.2M
Net Calls Change
-$79.7M

Top Buyers

1
BTI
Blue Trust Inc
Georgia
+$14K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.29B
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$1.21B
3
BlackRock
BlackRock
New York
-$1.12B
4
State Street
State Street
Massachusetts
-$509M
5
Primecap Management
Primecap Management
California
-$370M
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
151
Putnam Investments
Massachusetts
– -$3.12M -12,684 Closed
Aviva
152
Aviva
United Kingdom
– -$3.08M -12,519 Closed
ASRS
153
Arizona State Retirement System
Arizona
– -$3.07M -12,510 Closed
Two Sigma Investments
154
Two Sigma Investments
New York
– -$3.06M -12,438 Closed
NEI
155
Northwest & Ethical Investments
Ontario, Canada
– -$3.05M -12,396 Closed
ECG
156
Edge Capital Group
Georgia
– -$2.95M -12,008 Closed
AB
157
Amalgamated Bank
New York
– -$2.94M -11,966 Closed
TC
158
TwinBeech Capital
New York
– -$2.93M -11,945 Closed
CAM
159
Congress Asset Management
Massachusetts
– -$2.89M -11,780 Closed
N
160
Natixis
France
– -$2.94M -11,682 Closed
Ensign Peak Advisors
161
Ensign Peak Advisors
Utah
– -$2.85M -11,596 Closed
Mirae Asset Global Investments
162
Mirae Asset Global Investments
South Korea
– -$2.79M -11,359 Closed
Mackenzie Financial
163
Mackenzie Financial
Ontario, Canada
– -$2.78M -11,313 Closed
Truist Financial
164
Truist Financial
North Carolina
– -$2.76M -11,239 Closed
FDCDDQ
165
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$2.72M -11,063 Closed
WorldQuant Millennium Advisors
166
WorldQuant Millennium Advisors
New York
– -$2.71M -11,051 Closed
FAF
167
Första AP-fonden
Sweden
– -$2.63M -10,700 Closed
CWM
168
Congress Wealth Management
Massachusetts
– -$2.59M -10,559 Closed
LPL Financial
169
LPL Financial
California
– -$2.56M -10,424 Closed
FAF
170
Fjarde Ap-fonden
Sweden
– -$2.57M -10,385 Closed
MML Investors Services
171
MML Investors Services
Massachusetts
– -$2.48M -10,106 Closed
CS
172
Candriam SCA
Luxembourg
– -$2.4M -9,786 Closed
Millennium Management
173
Millennium Management
New York
– -$2.36M -9,614 Closed
TAF
174
Tredje AP-fonden
Sweden
– -$2.31M -9,389 Closed
MJB
175
Mark J. Bradley
– -$2.3M -9,375 Closed
5 6
7
8 9

ABMD Hedge Fund Activity: Q4 2022 in Review

8 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q4 2022, worth a combined $4.62M — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 499 funds closed out of ABMD and 0 opened new positions — a net loss of 499 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $14K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.29B sold.

  • 8 institutional investors held Abiomed Inc (ABMD) as of Q4 2022, down from 517 in Q3 2022.
  • Funds reported $4.62M of Abiomed Inc stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Abiomed Inc positions in Q4 2022 and 499 closed out, a net change of -499 holders.
  • The largest Abiomed Inc buyer in Q4 2022 was Blue Trust Inc, an estimated $14K added.
  • The largest Abiomed Inc seller in Q4 2022 was Vanguard Group, an estimated $1.29B sold.

Based on aggregated 13F filings for Q4 2022.